Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation Drops), End User, Indications - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global ophthalmic drops market is charting a robust growth course, as detailed in a new research publication now available on our website. The industry's market size was valued at USD 1.22 billion in 2023 and is anticipated to expand at a CAGR of 7.11%, reaching USD 1.98 billion by the year 2030. This remarkable growth trajectory is influenced by the increased demand for prescription eye drops and an aging population vulnerable to ocular conditions.
The FPNV Positioning Matrix featured in the report offers an indispensable analysis for business leaders and stakeholders. This matrix serves as a keen evaluation tool, providing insights into vendor performance and product satisfaction, and classifying them into four distinct categories of market success.
Furthermore, an in-depth Market Share Analysis presents an extensive examination of vendor positioning within the market spectrum during the assessed period. This analysis leverages critical data on revenue contribution, customer reach, and other strategic metrics, supplying key competitive intelligence that aids market players in decision-making.
An elaborate section on Key Company Profiles outlines the recent developments and strategic initiatives of top-tier vendors within the ophthalmic drops domain. These profiles cover an array of industry leaders pioneering in the ophthalmic sector, offering their innovative solutions to the market.
With a comprehensive Market Segmentation & Coverage, the report elucidates the market dynamics across various segments including type, category, end user, and indications. It also provides an extensive regional analysis covering the Americas, Asia-Pacific, and Europe, Middle East & Africa, with specific country-level insights.
Key Report Offerings:
- Strategic Insights: Unveiling market penetration strategies, highlighting expansion in emerging markets, and providing a blueprint for market diversification.
- Product Development and Innovation: Focusing on upcoming technologies, R&D activities, and new product developments in the ophthalmic drops market.
- Competitive Landscape: Offering an in-depth assessment of the strategic positioning and market dominance of major industry players.
The comprehensive research publication addresses pertinent questions related to market size, recommended strategic approaches, technological trends, and regulatory frameworks shaping the industry.
In a dynamic healthcare sector where eye health is gaining prominence, this report is an invaluable asset for stakeholders, investors, and industry professionals seeking to understand market dynamics and capitalize on growth opportunities in the ophthalmic drops market.
Key Topics Covered:
- Market Insights
- Understanding the Ophthalmic Drops Market
- Market Dynamics: Drivers, Restraints, Opportunities, and Challenges
- Trend Analysis and Cumulative Impact of High Inflation
- Market Segmentation
- Analysis of Market Segments and Trends
- Types of Ophthalmic Drops: Over-the-counter vs. Prescription
- Categories: Anesthetic, Antibiotic, Dilation, Glaucoma, Steroid
- Regional Analysis
- Americas, Asia-Pacific, Europe, Middle East & Africa Markets
- Insights on Regional Trends and Market Dynamics
- Competitive Landscape
- FPNV Positioning Matrix
- Market Share Analysis and Competitive Scenario
- Key Players and their Competitive Portfolio
- Future Outlook
- Emerging Opportunities and Market Projections
- Regulatory Framework and Industry Trends
Key Attributes
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $1.31 Billion |
| Forecasted Market Value (USD) by 2030 | $1.98 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
Companies Mentioned
- AbbVie Inc.
- Akorn, Inc.
- Alcon Inc.
- Amneal Pharmaceuticals, Inc.
- Apotex Inc.
- Bausch & Lomb Incorporated
- Catalent, Inc.
- CVS Health
- Duopharma Biotech Berhad
- Geri-Care Pharmaceuticals Corp.
- Honeywell International Inc.
- ImprimisRx
- Johnson & Johnson Services, Inc.
- KC Pharmaceuticals, Inc.
- Mankind Pharma Ltd.
- Mylan N.V.
- Novartis AG
- OCuSOFT, Inc.
- Orimed Pharma Inc.
- Pfizer, Inc.
- Preferred Pharmaceuticals Inc.
- Prestige Consumer Healthcare Inc.
- ROHTO Pharmaceutical Co., Ltd.
- Sager Pharma Kft.
- Santen Pharmaceutical Co., Ltd.
- Similasan Corporation
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wockhardt
For more information about this report visit https://www.researchandmarkets.com/r/kyltwu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
